Pediatric Drugs

Papers
(The H4-Index of Pediatric Drugs is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Alirocumab: Pediatric First Approval70
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department48
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives47
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature45
Treatment Options for Alopecia Areata in Children and Adolescents38
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy35
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?34
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review32
Recent Advances in the Management of Seizures in Children29
Managing Lupus Nephritis in Children and Adolescents28
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways24
Intranasal Analgesia in Preterm and Term Neonates22
Commercial Versus Compounded Preparations in Pediatric Ophthalmology21
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study20
History and Current Status of Growth Hormone Treatment in Children19
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study19
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark18
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products18
0.031060934066772